SAN

100.78

+1.63%↑

SHL.DE

48.13

-2.9%↓

ARGX

546.2

+3.64%↑

FRE

39.63

+2.4%↑

PHIA

22.7

-1.09%↓

SAN

100.78

+1.63%↑

SHL.DE

48.13

-2.9%↓

ARGX

546.2

+3.64%↑

FRE

39.63

+2.4%↑

PHIA

22.7

-1.09%↓

SAN

100.78

+1.63%↑

SHL.DE

48.13

-2.9%↓

ARGX

546.2

+3.64%↑

FRE

39.63

+2.4%↑

PHIA

22.7

-1.09%↓

SAN

100.78

+1.63%↑

SHL.DE

48.13

-2.9%↓

ARGX

546.2

+3.64%↑

FRE

39.63

+2.4%↑

PHIA

22.7

-1.09%↓

SAN

100.78

+1.63%↑

SHL.DE

48.13

-2.9%↓

ARGX

546.2

+3.64%↑

FRE

39.63

+2.4%↑

PHIA

22.7

-1.09%↓

Search

EssilorLuxottica SA

Open

SectorGezondheidszorg

254 -4.51

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

252.8

Max

268.5

Belangrijke statistieken

By Trading Economics

Inkomsten

-371M

994M

Verkoop

-72M

13B

K/W

Sectorgemiddelde

51.836

63.778

EPS

2.976

Dividendrendement

1.48

Winstmarge

7.52

Werknemers

153,498

EBITDA

635M

3.6B

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+7.78% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.48%

2.39%

Volgende Winsten

17 apr 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1.2B

122B

Vorige openingsprijs

258.51

Vorige sluitingsprijs

254

Nieuwssentiment

By Acuity

13%

87%

20 / 386 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bearish Evidence

EssilorLuxottica SA Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

12 feb 2025, 18:35 UTC

Winsten

Ray-Ban Maker EssilorLuxottica Logs Higher Sales Amid North America, China Growth -- Update

12 feb 2025, 17:32 UTC

Winsten

Ray-Ban Maker EssilorLuxottica Posts Higher Profit on Sales Growth

2 jan 2025, 17:29 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica Buys AI Startup in Hearing Market Push

28 mrt 2025, 08:57 UTC

Marktinformatie

EssilorLuxottica Should Be Able to Cope With U.S. Volatility -- Market Talk

13 feb 2025, 11:05 UTC

Marktinformatie
Winsten

EssilorLuxottica Seems Poised to Ride the Technology Wave -- Market Talk

13 feb 2025, 10:54 UTC

Marktinformatie
Winsten

EssilorLuxottica's Midterm Margin Target Seems Challenging -- Market Talk

13 feb 2025, 08:41 UTC

Marktinformatie
Winsten

EssilorLuxottica's Sales Are Better Than Expected -- Market Talk

12 feb 2025, 17:05 UTC

Winsten

EssilorLuxottica Backs Mid-Term Targets

12 feb 2025, 17:05 UTC

Winsten

EssilorLuxottica 2024 Oper Pft EUR3.45B

12 feb 2025, 17:04 UTC

Winsten

Analysts Had Seen EssilorLuxottica 2024 Net Pft at EUR2.50B

12 feb 2025, 17:04 UTC

Winsten

EssilorLuxottica 2024 Net Pft EUR2.36B

12 feb 2025, 17:03 UTC

Winsten

EssilorLuxottica 2024 Rev EUR26.51B

12 feb 2025, 17:03 UTC

Winsten

EssilorLuxottica 4Q Rev EUR6.78B

12 feb 2025, 17:01 UTC

Winsten

Analysts Had Seen EssilorLuxottica 4Q Rev at EUR6.68B

12 feb 2025, 17:00 UTC

Winsten

EssilorLuxottica Declares Dividend of EUR3.95 a share

11 feb 2025, 16:30 UTC

Marktinformatie

EssilorLuxottica Has Bright Future Ahead Amid Smart Glasses Push -- Market Talk

11 feb 2025, 10:58 UTC

Marktinformatie
Acquisities, Fusies, Overnames

EssilorLuxottica Continues Ophthalmology Expansion With Cellview Acquisition -- Market Talk

11 feb 2025, 07:03 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica Doesn't Disclose Financial Details

11 feb 2025, 07:03 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica Aims to Build Wider Portfolio of Ophthalmic Instruments, Services With Deal

11 feb 2025, 07:02 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica: Toronto-Based Cellview Specializes in Diagnostic via Retinal Imaging

11 feb 2025, 07:01 UTC

Acquisities, Fusies, Overnames

EssilorLuxottic Acquires Canadian Med-Tech Startup Cellview

11 feb 2025, 07:00 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica to Buy Cellview

2 jan 2025, 17:04 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica Didn't Disclose Financial Details

2 jan 2025, 17:03 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica: This Allows People With Hearing Impairment to Better Understand Speech

2 jan 2025, 17:02 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica: Pulse Audition Delivers AI-based Noise Reduction, Voice Enhancement

2 jan 2025, 17:01 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica Acquires Pulse Audition

2 jan 2025, 17:00 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica Strengthens Its Presence in Hearing Space With Acquisition of AI-driven Tech Startup in France

3 dec 2024, 16:21 UTC

Marktinformatie

EssilorLuxottica Could Be Hit by U.S. Tariffs -- Market Talk

6 nov 2024, 09:01 UTC

Marktinformatie

European Luxury Stocks Get Boost From Trump Potential Win -- Market Talk

18 okt 2024, 07:08 UTC

Marktinformatie
Winsten

EssilorLuxottica Tries Soothe Nerves After Revenue Misses Forecasts -- Market Talk

Peer Vergelijking

Prijswijziging

EssilorLuxottica SA Prognose

Koersdoel

By TipRanks

7.78% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 288.2 EUR  7.78%

Hoogste 335 EUR

Laagste 245 EUR

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor EssilorLuxottica SA - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

7

Buy

4

Hold

0

Sell

Technische score

By Trading Central

266.2 / 267.9Steun & Weerstand

Korte Termijn

Strong Bearish Evidence

Gemiddeld Termijn

Strong Bearish Evidence

Lange Termijn

No Evidence

Sentiment

By Acuity

20 / 386 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over EssilorLuxottica SA

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.